# A Phase IV Study of Huazhi Rougan Granule in the Treatment of Non-alcoholic Simple Fatty Liver

> **NCT06202456** · PHASE4 · COMPLETED · sponsor: **Shandong New Time Pharmaceutical Co., LTD** · enrollment: 2007 (actual)

## Conditions studied

- Efficacy and Safety

## Interventions

- **DRUG:** Huazhi Rougan granule

## Key facts

- **NCT ID:** NCT06202456
- **Lead sponsor:** Shandong New Time Pharmaceutical Co., LTD
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-13
- **Primary completion:** 2022-06-09
- **Final completion:** 2022-06-09
- **Target enrollment:** 2007 (ACTUAL)
- **Last updated:** 2024-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06202456

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06202456, "A Phase IV Study of Huazhi Rougan Granule in the Treatment of Non-alcoholic Simple Fatty Liver". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06202456. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*